A Longitudinal Study of COVID-19 Sequelae and Immunity | MicrobiomeTrials← Back to trialsNCT04411147
A Longitudinal Study of COVID-19 Sequelae and Immunity
RecruitingOBSERVATIONAL
Trial Details
Start: 2020-06-17Est. Completion: 2027-12-31
Enrollment target: 583 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
CancerImmunotherapy
The investigators wish to set up a pharmaco-epidemiological cohort within the Hospital Territorial Groups of the Cévenne…
Nîmes, FranceCompleted Sep 16, 2022
Long COVID
This two-year study will evaluate the feasibility and safety of an exercise + cognitive training program to improve neur…
Palo Alto, United StatesEst. completion Dec 31, 2026
Respiratory Tract InfectionSmell DisorderInfluenzaRhinosinusitisCOVID-19DepressionParosmiaHyposomiaNormosomiaAnosmia
Background:
Loss of the sense of smell can seriously affect a person's quality of life. The ability to smell can be dam…
Bethesda, United StatesCompleted Sep 30, 2029